Daniel E. Gómez

7.5k total citations · 2 hit papers
130 papers, 5.9k citations indexed

About

Daniel E. Gómez is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Daniel E. Gómez has authored 130 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Molecular Biology, 33 papers in Cancer Research and 24 papers in Oncology. Recurrent topics in Daniel E. Gómez's work include Protease and Inhibitor Mechanisms (19 papers), Immunotherapy and Immune Responses (13 papers) and Glycosylation and Glycoproteins Research (12 papers). Daniel E. Gómez is often cited by papers focused on Protease and Inhibitor Mechanisms (19 papers), Immunotherapy and Immune Responses (13 papers) and Glycosylation and Glycoproteins Research (12 papers). Daniel E. Gómez collaborates with scholars based in Argentina, United States and Cuba. Daniel E. Gómez's co-authors include Daniel F. Alonso, Unnur P. Thorgeirsson, Hitoshi Yoshiji, Hernán G. Fariña, Masabumi Shibuya, Romina Armando, Mariano R. Gabri, Pablo Lorenzano Menna, Águeda M. Tejera and Giselle V. Ripoll and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and SHILAP Revista de lepidopterología.

In The Last Decade

Daniel E. Gómez

127 papers receiving 5.7k citations

Hit Papers

Tissue inhibitors of metalloproteinases: structure, regul... 1997 2026 2006 2016 1997 2004 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel E. Gómez Argentina 37 2.6k 1.9k 1.4k 883 631 130 5.9k
David H. Lovett United States 50 2.5k 0.9× 1.8k 1.0× 995 0.7× 693 0.8× 1.0k 1.6× 126 6.6k
Toni Antalis United States 40 2.5k 0.9× 1.1k 0.6× 846 0.6× 876 1.0× 838 1.3× 91 5.7k
Daniel F. Alonso Argentina 36 2.5k 0.9× 1.5k 0.8× 1.2k 0.8× 376 0.4× 822 1.3× 154 5.0k
Thomas Pap Germany 48 3.4k 1.3× 1.2k 0.7× 1.7k 1.2× 692 0.8× 1.4k 2.2× 199 8.1k
Taro Hayakawa Japan 42 1.8k 0.7× 2.4k 1.3× 1.6k 1.1× 815 0.9× 283 0.4× 140 5.7k
Fabien Calvo France 45 3.3k 1.2× 790 0.4× 2.3k 1.6× 601 0.7× 842 1.3× 160 6.7k
Richard N. Harkins United States 30 3.8k 1.4× 925 0.5× 1.3k 0.9× 1.3k 1.5× 1.2k 2.0× 58 7.4k
John M. Clements United Kingdom 35 1.8k 0.7× 1.7k 0.9× 1.3k 0.9× 717 0.8× 871 1.4× 55 5.0k
David A. Lomas United Kingdom 44 4.3k 1.6× 3.6k 1.9× 1.6k 1.1× 1.5k 1.7× 555 0.9× 135 8.8k
Éric Boilard Canada 45 3.5k 1.3× 1.1k 0.6× 727 0.5× 1.6k 1.9× 1.7k 2.6× 125 7.1k

Countries citing papers authored by Daniel E. Gómez

Since Specialization
Citations

This map shows the geographic impact of Daniel E. Gómez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Gómez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Gómez more than expected).

Fields of papers citing papers by Daniel E. Gómez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Gómez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Gómez. The network helps show where Daniel E. Gómez may publish in the future.

Co-authorship network of co-authors of Daniel E. Gómez

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel E. Gómez. A scholar is included among the top collaborators of Daniel E. Gómez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel E. Gómez. Daniel E. Gómez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arnoso, Maitane, et al.. (2023). European attachment and restrictive and inclusive policies towards ethnic minorities and immigrants: The mediating role of perceived threat. Group Processes & Intergroup Relations. 27(6). 1304–1330.
2.
Cardama, Georgina A., et al.. (2023). Key role of PIN1 in telomere maintenance and oncogenic behavior in a human glioblastoma model. Oncology Reports. 49(5). 4 indexed citations
3.
Cardama, Georgina A., Nazareno González, Hugo H. Ortega, et al.. (2022). Preclinical Efficacy and Toxicology Evaluation of RAC1 Inhibitor 1A-116 in Human Glioblastoma Models. Cancers. 14(19). 4810–4810. 5 indexed citations
4.
Armando, Romina, et al.. (2019). Telomeropathies: Etiology, diagnosis, treatment and follow‐up. Ethical and legal considerations. Clinical Genetics. 96(1). 3–16. 21 indexed citations
5.
Armando, Romina, et al.. (2018). Homology Model and Docking-Based Virtual Screening for Ligands of Human Dyskerin as New Inhibitors of Telomerase for Cancer Treatment. International Journal of Molecular Sciences. 19(10). 3216–3216. 18 indexed citations
6.
Armando, Romina, et al.. (2016). AZT exerts its antitumoral effect by telomeric and non-telomeric effects in a mammary adenocarcinoma model. Oncology Reports. 36(5). 2731–2736. 15 indexed citations
7.
Armando, Romina, et al.. (2016). Telomerase as a Cancer Target. Development of New Molecules. Current Topics in Medicinal Chemistry. 16(22). 2432–2440. 62 indexed citations
9.
Orlando, Ulises, Juan Garona, Giselle V. Ripoll, et al.. (2012). The Functional Interaction between Acyl-CoA Synthetase 4, 5-Lipooxygenase and Cyclooxygenase-2 Controls Tumor Growth: A Novel Therapeutic Target. PLoS ONE. 7(7). e40794–e40794. 55 indexed citations
10.
Argibay, Pablo, et al.. (2010). Dietary factors, genetic and epigenetic influences in colorectal cancer. Experimental and Therapeutic Medicine. 1(2). 241–250. 5 indexed citations
11.
Gabri, Mariano R., et al.. (2009). Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines. Journal of Experimental & Clinical Cancer Research. 28(1). 146–146. 24 indexed citations
12.
Brines, Michael, Giovanni Grasso, Fabio Fiordaliso, et al.. (2004). Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor. Proceedings of the National Academy of Sciences. 101(41). 14907–14912. 527 indexed citations breakdown →
13.
Fariña, Hernán G., Débora Rosa Bublik, Daniel F. Alonso, & Daniel E. Gómez. (2002). Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cells. Clinical & Experimental Metastasis. 19(6). 551–560. 54 indexed citations
14.
Reuter, Jon D., Daniel E. Gómez, Jean H. Wilson, et al.. (2002). Intranasal Vaccination with a Recombinant Vesicular Stomatitis Virus Expressing Cottontail Rabbit Papillomavirus L1 Protein Provides Complete Protection against Papillomavirus-Induced Disease. Journal of Virology. 76(17). 8900–8909. 63 indexed citations
15.
Alonso, Daniel F. & Daniel E. Gómez. (1999). Cáncer mamario y colesterol. Ciencia hoy. 9(54). 42–47. 1 indexed citations
16.
17.
Ghiso, Julio A. Aguirre, Daniel F. Alonso, Eduardo Farias, Daniel E. Gómez, & Elisa Bal de Kier Joffé. (1999). Deregulation of the signaling pathways controlling urokinase production. European Journal of Biochemistry. 263(2). 295–304. 166 indexed citations
18.
Alonso, Daniel F., et al.. (1997). Modulation of growth and urokinase secretion by vasopressin and closely related nonapeptides in metastatic mouse mammary tumor cells. International Journal of Oncology. 10(2). 375–9. 7 indexed citations
19.
Gómez, Daniel E., Daniel F. Alonso, Hitoshi Yoshiji, & Unnur P. Thorgeirsson. (1997). Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.. PubMed. 74(2). 111–22. 1280 indexed citations breakdown →
20.
Rao, C.N., Daniel E. Gómez, David T. Woodley, & Unnur P. Thorgeirsson. (1995). Partial Characterization of Novel Serine Proteinase Inhibitors from Human Umbilical Vein Endothelial Cells. Archives of Biochemistry and Biophysics. 319(1). 55–62. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026